...
首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >The glucocorticoid receptor type Ⅱ complex is a target of the HIV-1 vpr gene product
【24h】

The glucocorticoid receptor type Ⅱ complex is a target of the HIV-1 vpr gene product

机译:糖皮质激素受体Ⅱ型复合物是HIV-1 vpr基因产物的靶标

获取原文
获取原文并翻译 | 示例
           

摘要

The vpr gene of human immunodeficiency virus type 1 (HIV-1) encodes a 15-kDa virion-associated protein that functions as a regulator of cellular processes linked to the HIV life cycle. We report the interaction of a 41-kDa cytosolic viral protein R interacting protein 1 (Rip-1) with Vpr in vitro. Rip-1 displays a wide tissue distribution, including relevant targets of HIV infection. Vpr protein induced nuclear translocation of Rip-1, as did glucocorticoid receptor (GR)-Ⅱ-stimulating steroids. Importantly, Vpr and Rip-1 coimmunoprecipitated with the human GR as part of an activated receptor complex. Vpr complementation of a vpr mutant virus was also mimicked by GR-Ⅱ-stimulating steroids. Vpr and GR-Ⅱ actions were inhibited by mifepristone, a GR-Ⅱ pathway inhibitor. Together these data directly link the activity of the vpr gene product to the glucocorticoid steroid pathway and provide a biochemical mechanism for the cellular and viral activity of Vpr, as well as suggest that a unique class of antivirals, which includes mifepristone (RU486), may influence HIV-1 replication.
机译:人类1型免疫缺陷病毒(HIV-1)的vpr基因编码一个15 kDa的病毒体相关蛋白,可作为与HIV生命周期相关的细胞过程的调节剂。我们报告了41 kDa胞质病毒蛋白R相互作用蛋白1(Rip-1)与Vpr的相互作用。 Rip-1显示出广泛的组织分布,包括HIV感染的相关目标。 Vpr蛋白诱导Rip-1的核易位,糖皮质激素受体(GR)-Ⅱ刺激类固醇也是如此。重要的是,Vpr和Rip-1与人类GR共免疫沉淀,是活化受体复合物的一部分。 vpr突变病毒的vpr互补也被GR-Ⅱ刺激的类固醇模拟。米非司酮是一种GR-Ⅱ途径的抑制剂,可抑制Vpr和GR-Ⅱ的作用。这些数据加在一起,直接将vpr基因产物的活性与糖皮质激素类固醇途径联系起来,并为Vpr的细胞和病毒活性提供了生化机制,并暗示一类独特的抗病毒药,包括米非司酮(RU486),可能影响HIV-1复制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号